The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction

We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,...

Full description

Saved in:
Bibliographic Details
Published inQJM : An International Journal of Medicine Vol. 91; no. 10; pp. 667 - 676
Main Author Yarnell, J.
Format Journal Article
LanguageEnglish
Published England 01.10.1998
Subjects
Online AccessGet full text
ISSN1460-2393
1460-2725
1460-2393
DOI10.1093/qjmed/91.10.667

Cover

Loading…
Abstract We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,592 men aged 50-59 years were recruited from 1991 to 1993, and examined for evidence of IHD at baseline. Subjects are followed annually by questionnaire. Clinical information is validated from hospital and GP records. Demographic characteristics were similar in all four centres. Body mass index was highest in Strasbourg (mean 27.4 kg/m2 vs. 26.3 kg/m2 in Toulouse and Belfast), but total cholesterol, triglyceride and fibrinogen were highest in Belfast. In Belfast, 6.1% reported having had a coronary angiogram, compared to 3.0% in Toulouse. Conversely, 13.8% in Toulouse reported taking lipid-lowering drugs vs. 1.6% in Belfast. As predicted, a history of myocardial infarction (MI) was highest in Belfast (6.1%) and lowest in Toulouse (1.2%). Some 7.1% of Belfast men reported a medical diagnosis of angina vs. 1.5% in Toulouse. Subjects showing evidence of pre-existing IHD will be studied prospectively but treated in the analysis as an additional variable. These results provide a measure of reassurance that these cohorts are representative of the communities from which they are drawn and provide a reliable baseline for prospective evaluation and cross-sectional comparisons. The levels of the classical risk factors found in this study, particularly when examined in combination, as multiple logistic functions based on previous British studies, are very similar between centres and cannot explain the large differences in the incidence of IHD which exist. Additional risk factors may help explain, at least in part, the major differences in incidence of IHD between these study centres.
AbstractList We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,592 men aged 50-59 years were recruited from 1991 to 1993, and examined for evidence of IHD at baseline. Subjects are followed annually by questionnaire. Clinical information is validated from hospital and GP records. Demographic characteristics were similar in all four centres. Body mass index was highest in Strasbourg (mean 27.4 kg/m2 vs. 26.3 kg/m2 in Toulouse and Belfast), but total cholesterol, triglyceride and fibrinogen were highest in Belfast. In Belfast, 6.1% reported having had a coronary angiogram, compared to 3.0% in Toulouse. Conversely, 13.8% in Toulouse reported taking lipid-lowering drugs vs. 1.6% in Belfast. As predicted, a history of myocardial infarction (MI) was highest in Belfast (6.1%) and lowest in Toulouse (1.2%). Some 7.1% of Belfast men reported a medical diagnosis of angina vs. 1.5% in Toulouse. Subjects showing evidence of pre-existing IHD will be studied prospectively but treated in the analysis as an additional variable. These results provide a measure of reassurance that these cohorts are representative of the communities from which they are drawn and provide a reliable baseline for prospective evaluation and cross-sectional comparisons. The levels of the classical risk factors found in this study, particularly when examined in combination, as multiple logistic functions based on previous British studies, are very similar between centres and cannot explain the large differences in the incidence of IHD which exist. Additional risk factors may help explain, at least in part, the major differences in incidence of IHD between these study centres.
We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,592 men aged 50-59 years were recruited from 1991 to 1993, and examined for evidence of IHD at baseline. Subjects are followed annually by questionnaire. Clinical information is validated from hospital and GP records. Demographic characteristics were similar in all four centres. Body mass index was highest in Strasbourg (mean 27.4 kg/m2 vs. 26.3 kg/m2 in Toulouse and Belfast), but total cholesterol, triglyceride and fibrinogen were highest in Belfast. In Belfast, 6.1% reported having had a coronary angiogram, compared to 3.0% in Toulouse. Conversely, 13.8% in Toulouse reported taking lipid-lowering drugs vs. 1.6% in Belfast. As predicted, a history of myocardial infarction (MI) was highest in Belfast (6.1%) and lowest in Toulouse (1.2%). Some 7.1% of Belfast men reported a medical diagnosis of angina vs. 1.5% in Toulouse. Subjects showing evidence of pre-existing IHD will be studied prospectively but treated in the analysis as an additional variable. These results provide a measure of reassurance that these cohorts are representative of the communities from which they are drawn and provide a reliable baseline for prospective evaluation and cross-sectional comparisons. The levels of the classical risk factors found in this study, particularly when examined in combination, as multiple logistic functions based on previous British studies, are very similar between centres and cannot explain the large differences in the incidence of IHD which exist. Additional risk factors may help explain, at least in part, the major differences in incidence of IHD between these study centres.We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,592 men aged 50-59 years were recruited from 1991 to 1993, and examined for evidence of IHD at baseline. Subjects are followed annually by questionnaire. Clinical information is validated from hospital and GP records. Demographic characteristics were similar in all four centres. Body mass index was highest in Strasbourg (mean 27.4 kg/m2 vs. 26.3 kg/m2 in Toulouse and Belfast), but total cholesterol, triglyceride and fibrinogen were highest in Belfast. In Belfast, 6.1% reported having had a coronary angiogram, compared to 3.0% in Toulouse. Conversely, 13.8% in Toulouse reported taking lipid-lowering drugs vs. 1.6% in Belfast. As predicted, a history of myocardial infarction (MI) was highest in Belfast (6.1%) and lowest in Toulouse (1.2%). Some 7.1% of Belfast men reported a medical diagnosis of angina vs. 1.5% in Toulouse. Subjects showing evidence of pre-existing IHD will be studied prospectively but treated in the analysis as an additional variable. These results provide a measure of reassurance that these cohorts are representative of the communities from which they are drawn and provide a reliable baseline for prospective evaluation and cross-sectional comparisons. The levels of the classical risk factors found in this study, particularly when examined in combination, as multiple logistic functions based on previous British studies, are very similar between centres and cannot explain the large differences in the incidence of IHD which exist. Additional risk factors may help explain, at least in part, the major differences in incidence of IHD between these study centres.
Author Yarnell, J.
Author_xml – sequence: 1
  givenname: J.
  surname: Yarnell
  fullname: Yarnell, J.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/10024924$$D View this record in MEDLINE/PubMed
BookMark eNp1kV9vFCEUxYmpsX_02Tdzn3zbXWBmZwbfTLPVTdraaH2eMHCxVBamwFb3e_qBZLZt0pj4BBx-53Iv55gc-OCRkLeMzhkV1eLudoN6IVg5zZumfUGOWN3QGa9EdfBsf0iOU7qllNZt3b0ih4xSXgteH5E_1zcIV1_XFytIeat3H0A5mZJV0kG06ScYqXKICXQAHzLg79FJ6yEXW8J7jNKZ4DRoawxG9AoTlOu9NRhQIQYv4w5uUMZcqIQyIQyYfyF6OIuyOEB6DZchlprRwzqiK8IcrmJII6ps7xFWo9W4scGFH_vWvk29Tg9c7IKSUduirb2RseDBvyYvjXQJ3zyuJ-T72er69PPs_Mun9enH85liHWtnquNc6GHgSKXsBsNNWzExcMEYo42osdOyo6ZdKkFZhd3AB1N13VDgquZCVifk_UPdMYa7Labcb2xS6Er_GLapbwRr6VLwAr57BLdDCawfo92UX-mfcijA4gFQZegU0TxD-inpfp90L9gklKSLY_mPQ9ksp-lzlNb91_cXoEezKw
CitedBy_id crossref_primary_10_1016_j_ijcard_2005_04_024
crossref_primary_10_1038_sj_ejhg_5201277
crossref_primary_10_1016_j_respe_2012_05_009
crossref_primary_10_1017_S0007114507842826
crossref_primary_10_1186_1471_2350_11_119
crossref_primary_10_3389_fcvm_2017_00073
crossref_primary_10_1093_ije_dyh267
crossref_primary_10_1373_clinchem_2010_152751
crossref_primary_10_1016_S0002_8703_99_70268_1
crossref_primary_10_1093_cid_cis489
crossref_primary_10_1002_sim_4130
crossref_primary_10_1093_eurheartj_ehp254
crossref_primary_10_1111_j_1538_7836_2004_00981_x
crossref_primary_10_1016_S0021_9150_03_00280_6
crossref_primary_10_1007_s12160_016_9784_x
crossref_primary_10_1016_S0007_9960_05_80496_1
crossref_primary_10_1161_01_CIR_0000084542_64687_97
crossref_primary_10_1161_01_ATV_0000022850_59845_E0
crossref_primary_10_1016_j_appet_2007_03_223
crossref_primary_10_1007_s11812_014_0067_9
crossref_primary_10_1161_JAHA_117_006389
crossref_primary_10_1038_ijo_2009_204
crossref_primary_10_1016_S0049_3848_01_00245_6
crossref_primary_10_1016_j_jad_2013_07_010
crossref_primary_10_1161_01_ATV_0000079512_66448_1D
crossref_primary_10_1161_01_CIR_0000016345_58696_4F
crossref_primary_10_1007_s00394_020_02455_2
crossref_primary_10_1007_s10654_013_9808_9
crossref_primary_10_1016_j_atherosclerosis_2005_06_017
crossref_primary_10_1186_1471_2334_5_61
crossref_primary_10_1093_ije_30_5_1057
crossref_primary_10_1093_qjmed_hcr128
crossref_primary_10_1016_j_atherosclerosis_2004_10_029
crossref_primary_10_1111_j_1538_7836_2005_01486_x
crossref_primary_10_1016_j_diabres_2016_07_010
crossref_primary_10_1038_jhh_2009_34
crossref_primary_10_1111_jcpe_12450
crossref_primary_10_1111_jcpe_12691
crossref_primary_10_1161_CIRCULATIONAHA_109_901413
crossref_primary_10_1093_europace_euw401
crossref_primary_10_1093_jnci_djw127
crossref_primary_10_1097_01_hjr_0000230097_81202_9f
crossref_primary_10_1111_j_1600_051X_2012_01923_x
crossref_primary_10_1097_00004872_200402000_00028
crossref_primary_10_1136_jech_2013_203053
crossref_primary_10_1016_j_atherosclerosis_2009_03_025
crossref_primary_10_1038_ajh_2011_94
crossref_primary_10_1111_j_1600_051X_2006_01030_x
crossref_primary_10_1017_S0007114520001518
crossref_primary_10_1097_HJH_0b013e3282fd991f
crossref_primary_10_1371_journal_pone_0273333
crossref_primary_10_1093_ije_dyq271
crossref_primary_10_1542_peds_2008_1118
crossref_primary_10_1002_ana_22669
crossref_primary_10_1016_S0021_9150_02_00026_6
crossref_primary_10_1016_S0167_5273_00_00283_7
crossref_primary_10_1016_j_ijcard_2014_09_102
crossref_primary_10_1016_S0007_9960_05_80464_X
crossref_primary_10_1111_j_1600_051X_2009_01468_x
crossref_primary_10_1097_PSY_0000000000000289
crossref_primary_10_1016_S0899_9007_00_00335_X
crossref_primary_10_1007_s11845_020_02498_8
crossref_primary_10_1016_j_atherosclerosis_2006_05_014
crossref_primary_10_1016_j_ypmed_2011_04_006
crossref_primary_10_1161_01_CIR_0000164203_54111_AE
crossref_primary_10_1016_j_annepidem_2007_01_017
crossref_primary_10_1016_j_ypmed_2013_04_003
crossref_primary_10_1161_01_CIR_0000099509_76044_A2
crossref_primary_10_1016_j_atherosclerosis_2011_05_034
crossref_primary_10_1161_01_CIR_0000120705_55512_EC
crossref_primary_10_1038_sj_ijo_0801635
crossref_primary_10_1111_jcpe_13377
crossref_primary_10_1016_S0021_9150_02_00309_X
crossref_primary_10_1161_01_ATV_0000248096_62495_73
crossref_primary_10_1177_1741826711417341
crossref_primary_10_1016_j_jad_2007_03_012
crossref_primary_10_1111_j_1540_8159_2000_tb00860_x
crossref_primary_10_1097_HJR_0b013e32830fe479
crossref_primary_10_1038_ejcn_2012_70
crossref_primary_10_1111_jcpe_13819
crossref_primary_10_1016_S1262_3636_07_70306_3
crossref_primary_10_1016_j_jdent_2019_103265
crossref_primary_10_1016_j_ijcard_2015_10_118
crossref_primary_10_1016_j_atherosclerosis_2009_07_018
crossref_primary_10_1093_ije_dyg038
crossref_primary_10_1016_j_atherosclerosis_2007_08_019
crossref_primary_10_17116_profmed201518324_30
crossref_primary_10_1097_00008469_200008000_00002
crossref_primary_10_1097_00004872_200303000_00017
crossref_primary_10_1097_01_hjr_0000136416_24769_42
crossref_primary_10_1046_j_1538_7836_2003_00398_x
crossref_primary_10_1111_jcpe_13510
crossref_primary_10_1016_j_jada_2005_09_004
crossref_primary_10_1111_j_1600_051X_2007_01075_x
crossref_primary_10_1079_BJN20041286
crossref_primary_10_1111_jcpe_13076
crossref_primary_10_1016_j_amjcard_2008_09_092
crossref_primary_10_1111_j_1600_051X_2008_01288_x
crossref_primary_10_1097_CEJ_0b013e328359cba7
crossref_primary_10_1093_ije_31_6_1227
crossref_primary_10_1161_ATVBAHA_112_300109
crossref_primary_10_1371_journal_pone_0285117
crossref_primary_10_1155_2009_543746
crossref_primary_10_1186_s12916_020_01776_7
crossref_primary_10_1016_S0021_9150_99_00484_0
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/qjmed/91.10.667
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2393
EndPage 676
ExternalDocumentID 10024924
10_1093_qjmed_91_10_667
Genre Multicenter Study
Journal Article
Comparative Study
GeographicLocations France
Northern Ireland
GeographicLocations_xml – name: Northern Ireland
– name: France
GroupedDBID ---
-E4
.2P
.55
.GJ
.I3
.XZ
.ZR
08G
0R~
123
18M
1TH
29P
2WC
354
3O-
4.4
482
48X
53G
5RE
5VS
5WA
5WD
70D
8F7
AABZA
AACZT
AAJKP
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAYEP
AAYXX
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPQP
ABPTD
ABQLI
ABQNK
ABVGC
ABWST
ABXVV
ABZBJ
ACGFS
ACUFI
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AEMDU
AEMQT
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGQPQ
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIJHB
AJBYB
AJEEA
AJNCP
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ASPBG
ATGXG
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CAG
CDBKE
CITATION
COF
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
M-Z
MHKGH
ML0
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OB2
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
TCURE
TEORI
TJX
TR2
VVN
W8F
WH7
WOQ
X7H
X7M
YAYTL
YKOAZ
YOC
YXANX
ZKX
~91
08P
6.Y
AAJQQ
AAPGJ
AAQQT
AAWDT
ABNGD
ABQTQ
ABSMQ
ACFRR
ACPQN
ACUTJ
ACZBC
ADJQC
ADRIX
AEHUL
AEKPW
AFFQV
AFSHK
AFXEN
AGKRT
AGMDO
APJGH
AQDSO
AQKUS
ATTQO
BZKNY
CGR
CUY
CVF
ECM
EIF
EIHJH
H13
M49
MBLQV
NPM
NTWIH
O~Y
RHF
TMA
ZXP
7X8
ID FETCH-LOGICAL-c1817-c8229dbb2e0aa8bf2f7319b291110694e8da80f75c9013e8b2bf388baa83429a3
ISSN 1460-2393
1460-2725
IngestDate Fri Sep 05 00:10:57 EDT 2025
Wed Feb 19 02:33:09 EST 2025
Thu Apr 24 23:12:51 EDT 2025
Tue Aug 05 12:02:32 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1817-c8229dbb2e0aa8bf2f7319b291110694e8da80f75c9013e8b2bf388baa83429a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://academic.oup.com/qjmed/article-pdf/91/10/667/9909871/910667.pdf
PMID 10024924
PQID 69170592
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_69170592
pubmed_primary_10024924
crossref_primary_10_1093_qjmed_91_10_667
crossref_citationtrail_10_1093_qjmed_91_10_667
PublicationCentury 1900
PublicationDate 1998-10-1
1998-Oct
19981001
PublicationDateYYYYMMDD 1998-10-01
PublicationDate_xml – month: 10
  year: 1998
  text: 1998-10-1
  day: 01
PublicationDecade 1990
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle QJM : An International Journal of Medicine
PublicationTitleAlternate QJM
PublicationYear 1998
References 11339214 - QJM. 2001 Mar;94(3):173-4
References_xml – reference: 11339214 - QJM. 2001 Mar;94(3):173-4
SSID ssj0004748
Score 1.5314909
Snippet We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 667
SubjectTerms Anthropometry
Blood Pressure
Coronary Disease - blood
Coronary Disease - epidemiology
Coronary Disease - physiopathology
Follow-Up Studies
France - epidemiology
Humans
Life Style
Lipids - blood
Male
Mass Screening - methods
Middle Aged
Northern Ireland - epidemiology
Prospective Studies
Risk Factors
Socioeconomic Factors
Title The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction
URI https://www.ncbi.nlm.nih.gov/pubmed/10024924
https://www.proquest.com/docview/69170592
Volume 91
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Jj9MwFICtMkiIC2KfDts7cECq0kniNIm5IdQyM5oOWyuVU2RnOaCSMKU9wH_g3_GDeM9LmhmoWC5R5dpJ5PfFfrbfwtjTHHVqKXiEmps_8qLALzwZBcLDpUFFU4oKlLa2OIuP5tHJYrTo9b53rJY2azXMv_3Wr-R_pIplKFfykv0HybY3xQL8jfLFK0oYr38t4zfvjqdjEyWWVvc5acO647XRuEunUzSDullTPP-ltJaNOCXSflTVLIs2TYoxz-rYm68a7a5Laa_X7jCnte3SSTnM8YM-_qGkasfkHFMXQ_JAcF6cg_E2Da1-tfcukvX0K06lq8IE_Kjwm2sxsfry25PpYOfepVWkp5fMAz7IVWu7Y-wHzbaG9vNzBnJuJI5i3wsT4xXthmoRdJH0OwNvbJJ6_DIhmGBZ5x8_0dbxRARYMrR1LwbfPnudTeanp9lsvJhdYVfDJNGn_q8WW4uhKNHJ2No3c5GiBD_UDzhsb39RydmxctEazOwmu2F7DF4Yjm6xXlnfZtdc791hPxAn0DiBxuk5tDABEQEWJigaQJjAwgQoeOjABB2YAP_WTZsKHEygYQILE1iYwMAEyA44mMDBBB2Y4BJMoGGiB2xhgi1Md9l8Mp69PPJs0g8vR2Uz8XLKQFAoFZa-lKmqwirBWUKFNCmTk3aZFjL1q2SUC9rBT1WoKp6mCitz1K0kv8f26qYu9xnEKarbXMiYlzwaJYmMU5VW2Fc8rATP8z4bOilluY2IT4lZlpmxzOCZFmsmAipAsfbZs7bBZxMMZnfVJ07sGQ7YdAon67LZfMliQRGsRNhn9w0NnVvp-J3RwR_bPmDXt9_MQ7a3Xm3KR6gcr9VjjexPFWrEjg
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+PRIME+study%3A+classical+risk+factors+do+not+explain+the+severalfold+differences+in+risk+of+coronary+heart+disease+between+France+and+Northern+Ireland.+Prospective+Epidemiological+Study+of+Myocardial+Infarction&rft.jtitle=QJM+%3A+An+International+Journal+of+Medicine&rft.au=Yarnell%2C+J+W&rft.date=1998-10-01&rft.issn=1460-2725&rft.volume=91&rft.issue=10&rft.spage=667&rft_id=info:doi/10.1093%2Fqjmed%2F91.10.667&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2393&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2393&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2393&client=summon